Friedman, C. F., Clark, V., Raikhel, A. V., Barz, T., Shoushtari, A. N., Momtaz, P., . . . Postow, M. A. (2017). Thinking Critically About Classifying Adverse Events: Incidence of Pancreatitis in Patients Treated With Nivolumab + Ipilimumab. JNCI : Journal of the National Cancer Institute, 109(4), . https://doi.org/10.1093/jnci/djw260
Chicago-Zitierstil (17. Ausg.)Friedman, Claire F., et al. "Thinking Critically About Classifying Adverse Events: Incidence of Pancreatitis in Patients Treated With Nivolumab + Ipilimumab." JNCI : Journal of the National Cancer Institute 109, no. 4 (2017). https://doi.org/10.1093/jnci/djw260.
MLA-Zitierstil (9. Ausg.)Friedman, Claire F., et al. "Thinking Critically About Classifying Adverse Events: Incidence of Pancreatitis in Patients Treated With Nivolumab + Ipilimumab." JNCI : Journal of the National Cancer Institute, vol. 109, no. 4, 2017, https://doi.org/10.1093/jnci/djw260.